Cargando…
Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of ir...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199627/ https://www.ncbi.nlm.nih.gov/pubmed/25329065 http://dx.doi.org/10.1371/journal.pone.0109880 |
_version_ | 1782339943480164352 |
---|---|
author | Hamilton, Jasmine L. Hatef, Azadeh Imran ul-haq, Muhammad Nair, Neelima Unniappan, Suraj Kizhakkedathu, Jayachandran N. |
author_facet | Hamilton, Jasmine L. Hatef, Azadeh Imran ul-haq, Muhammad Nair, Neelima Unniappan, Suraj Kizhakkedathu, Jayachandran N. |
author_sort | Hamilton, Jasmine L. |
collection | PubMed |
description | Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity. |
format | Online Article Text |
id | pubmed-4199627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41996272014-10-21 Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function Hamilton, Jasmine L. Hatef, Azadeh Imran ul-haq, Muhammad Nair, Neelima Unniappan, Suraj Kizhakkedathu, Jayachandran N. PLoS One Research Article Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity. Public Library of Science 2014-10-16 /pmc/articles/PMC4199627/ /pubmed/25329065 http://dx.doi.org/10.1371/journal.pone.0109880 Text en © 2014 Hamilton et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hamilton, Jasmine L. Hatef, Azadeh Imran ul-haq, Muhammad Nair, Neelima Unniappan, Suraj Kizhakkedathu, Jayachandran N. Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title | Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title_full | Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title_fullStr | Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title_full_unstemmed | Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title_short | Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function |
title_sort | clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199627/ https://www.ncbi.nlm.nih.gov/pubmed/25329065 http://dx.doi.org/10.1371/journal.pone.0109880 |
work_keys_str_mv | AT hamiltonjasminel clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction AT hatefazadeh clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction AT imranulhaqmuhammad clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction AT nairneelima clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction AT unniappansuraj clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction AT kizhakkedathujayachandrann clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction |